← All trials
NCT04633772
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 5, 2020
- Primary completion
- Feb 1, 2021
- Completion date
- Feb 28, 2021
- First posted
- Nov 18, 2020
- Last posted
- Nov 23, 2020
- Enrollment
- 130
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Erasmus University RotterdamLead sponsor
- Federal University of Minas GeraisOverall official - principal investigator
- Federal University of Minas GeraisCollaborator
- Erasmus University RotterdamOverall official - principal investigator
- AngitecCollaborator
- AngitexOverall official - principal investigator
- Fonds Erasme pour la Recherche MedicaleCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.